Refine your search
334 results found
Hogan Lovells | USA | 18 May 2022
D.C. District Court rules for PhRMA in PBM accumulator programs Final Rule litigation
On Tuesday, May 17, 2022, the U.S. District Court for the District of Columbia issued a decision granting the Pharmaceutical Research and…
Kramer Levin Naftalis & Frankel LLP | USA | 29 Jan 2020
USMCA: Implications for Biologics and Innovation
On Wednesday, President Donald Trump signed the United States-Mexico-Canada Agreement (USMCA) into law. The USMCA contains a number of key and…
Mintz | USA | 2 Nov 2018
ML Strategies Health Care Lame Duck Preview
With the opioid bill passed, the House on recess and the Senate having cut a deal to get out the door, we all begin to wonder: after the dust settles…
Bristows | European Union, USA | 29 Oct 2018
CLIP of the month: Does orphan drug pricing pose an antitrust problem?
In the USA, a rare or orphan disease is defined as affecting fewer than 200,000 people and more than 7,000 rare diseases have been identified to date…
Hogan Lovells | USA | 23 Oct 2018
CMS proposes requiring drug prices in TV ads
On October 15, CMS released a proposed rule titled “Medicare and Medicaid Programs: Drug Pricing Transparency,” which would require direct-to-consumer…
Arent Fox LLP | USA | 5 Sep 2018
PhRMA Faces Setback - For Now - In Challenge to California’s New Drug Price Transparency Law
On August 28, 2018, the United States District Court for the Eastern District of California (the Court) dismissed with leave to amend the…
Cooley LLP | USA | 31 Aug 2018
Court Dismisses Lawsuit Challenging CA S.B. 17 But Gives Leave to Amend
This week a California judge dismissed a lawsuit filed in December 2017 by the Pharmaceutical Research and Manufacturers of America (PhRMA)…
Banner Witcoff | USA | 30 Aug 2018
Does Secret Prior Art Survive in the AIA? Twelve Interested Parties Weigh In
In May, a panel of the U.S. Court of Appeals for the Federal Circuit applied an on-sale bar under the America Invents Act (AIA) to Helsinn's U.S…
Mintz | USA | 12 Mar 2018
ML Strategies Health Care Preview Week of March 12th
This week, Congress returns to Washington with 11 days to finalize a government spending bill. House appropriators will be meeting throughout the week…
Gordon Rees Scully Mansukhani | USA | 25 Jan 2018
Will Massachusetts be able to negotiate Medicaid prescription drug prices?
In the absence of new federal policies to tame high price drugs, Massachusetts’ state Medicaid program is fighting for the power to negotiate…
